Balyasny Asset Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Buy
59,200
+25,800
+77% +$5.29M 0.01% 1017
2025
Q4
$8.55M Sell
33,400
-80,800
-71% -$21.2M 0.01% 1106
2025
Q3
$29.7M Sell
114,200
-8,500
-7% -$2.24M 0.04% 544
2025
Q2
$30M Buy
122,700
+17,600
+17% +$4.39M 0.05% 518
2025
Q1
$27.8M Sell
105,100
-16,800
-14% -$4.54M 0.05% 478
2024
Q4
$30.9M Sell
121,900
-32,000
-21% -$8.58M 0.05% 488
2024
Q3
$48.7M Buy
153,900
+56,200
+58% +$20M 0.08% 313
2024
Q2
$36.5M Buy
97,700
+84,100
+618% +$28.4M 0.06% 387
2024
Q1
$4.72M Buy
13,600
+2,200
+19% +$834K 0.01% 1251
2023
Q4
$5.22M Sell
11,400
-26,000
-70% -$12.8M 0.01% 1102
2023
Q3
$18.2M Buy
+37,400
New +$17.6M 0.04% 606
2021
Q3
Sell
-1,900
Closed -$841K 2149
2021
Q2
$841K Buy
+1,900
New +$830K ﹤0.01% 1367
2016
Q3
Sell
-153,100
Closed -$27.5M 1120
2016
Q2
$27.5M Buy
+153,100
New +$27.2M 0.18% 153

Other funds holding HUM

Balyasny Asset Management's HUM Position: Q1 2026 in Review

Balyasny Asset Management increased its Humana (HUM) stake by 92% in Q1 2026, buying an estimated $5.23M and bringing the position to 53,226 shares worth $9.23M. The position accounts for 0.01% of the portfolio, ranked #1072.

Balyasny Asset Management first reported a position in HUM in Q2 2013 and has held it in 43 quarters since. The position peaked at $122M in Q2 2024. 780 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Balyasny Asset Management held 53,226 shares of Humana worth $9.23M as of Q1 2026.
  • Balyasny Asset Management bought 25,504 Humana shares in Q1 2026, an estimated $5.23M.
  • Humana made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1072 holding.
  • Balyasny Asset Management first reported a position in Humana in Q2 2013 and has held it in 43 quarters since.
  • Balyasny Asset Management's Humana position peaked at $122M in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.